Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise

NCT ID: NCT05025774

Last Updated: 2025-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

90 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-14

Study Completion Date

2026-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to more accurately assess cardiac function, ventilation and exercise capacity in a non-invasive fashion, and to better characterize exercise intolerance in the setting of three populations of individuals with chronic diseases of childhood (acute lymphoblastic leukemia (ALL), chronic lung disease (CLD) of prematurity, and post-heart transplant (HT))

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Physical activity in childhood is an integral part of maintaining health and quality of life. Children who participate in routine physical activity are more likely to maintain a healthy body weight and are less likely to have heart disease, type 2 diabetes and high blood pressure as adults. Children with chronic disease are often limited from full participation in exercise for various reasons -perceived physical limitations, either from the patient and family or from their medical provider, or because of symptoms which cause exercise to feel uncomfortable. As the number of children living and aging with chronic disease continues to grow, the researchers are hoping to expand the current exercise testing capabilities for both clinical care and research in order to (i) provide data to permit formulation of evidence-based guidelines for exercise in chronic childhood disease; (ii) improve understanding of limitations to exercise in this growing population; (iii) learn long-term implications of chronic childhood disease as these individuals enter adulthood.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Lung Disease Chronic Obstructive Pulmonary Disease Acute Lymphoblastic Leukemia Heart Transplant

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Case

Adolescent or young adult acute lymphoblastic leukemia survivor, OR living with chronic lung disease of prematurity, OR living with heart transplant

Physical activity

Intervention Type OTHER

Participant Reported Physical Activity and Outcomes (completed via REDCap or on paper)

Control

14-25 years old healthy individuals who are ambulatory without assistance. We may enroll younger subjects but we wish to subjects to match our patient population

Physical activity

Intervention Type OTHER

Participant Reported Physical Activity and Outcomes (completed via REDCap or on paper)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physical activity

Participant Reported Physical Activity and Outcomes (completed via REDCap or on paper)

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Cases:

* Acute lymphoblastic leukemia survivor, OR living with chronic lung disease of prematurity, OR living with heart transplant
* 8-25 years old
* Height: ≥ 48 inches
* Ambulatory without assistance
* English speaking
* Normotensive (\<95th percentile for age; okay if managed with antihypertensive medication)
* SpO2 \>92%
* Not pregnant
* ALL survivor specific: must have completed therapy ≥ 3 months prior to study entry
* Controls

* 8-25 years old
* Height: ≥ 48 inches
* Ambulatory without assistance
* English speaking
* No history of arrhythmia or known cardiac dysfunction at baseline
* Normotensive (\<95th percentile for age; okay if managed with antihypertensive medication)
* SpO2 \>95%
* Not pregnant

Exclusion Criteria

* Cases:

* ALL specific: received cranial radiation, bone marrow transplant recipients
* Investigator or patient's primary physician deems the patient unsuitable for the study
* Controls:

* History of malignancy, CLD or HT or any other diagnosis which may reduce cardiorespiratory function
* Investigator deems the patient unsuitable for the study
Minimum Eligible Age

8 Years

Maximum Eligible Age

25 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Masonic Cancer Center, University of Minnesota

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Pianosi Paolo, MD

Role: PRINCIPAL_INVESTIGATOR

Masonic Children's Hospital, University of Minnesota

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Masonic Cancer Center

Minneapolis, Minnesota, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Char Napurski, MPH, CCRP

Role: CONTACT

612-626-2140

Pianosi Paolo, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lucie Turcotte, MD, MPH, MS

Role: primary

612-624-1818

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PEDS-2021-29482

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Breathing Exercises on Lung Function
NCT06472167 RECRUITING NA
Lung Cancer Rehabilitation Study
NCT01258478 UNKNOWN NA